Immune-Evasive Islets Show Promise in Type 1 Diabetes Trial – Medscape
- Immune-Evasive Islets Show Promise in Type 1 Diabetes Trial Medscape
- First FDA-approved islet transplant at UI Health ends insulin dependence News-Medical
- After decades, UI Health-developed diabetes therapy leaves realm of experimental Crain’s Chicago Business
- New Cell Transplant Treatment Offers Hope for Type 1 Diabetics Goodnet | Gateway to doing good
- Type 1 Diabetes Patient’s Insulin Production Restored with New Cell Transplant Therapy Scientific American